NASDAQ:BLCM
Delisted

Bellicum Pharmaceuticals Stock Signals

etoro logo Buy BLCM
*Your capital is at risk
$0.0748
+0 (+0%)
At Close: Jun 03, 2024

Latest Data & Signals Issued

Below are some of the latest signals issued for Bellicum Pharmaceuticals

General

Signal Type Signal Value Data
Score 0.000 62 days ( 0 %
Last Price $0.0748 0 %
Performance History
7 Days
$0.0748 $0.0748
0%
30 Days
$0.0748 $0.0748
0%
12 Mos
$0.300 $0.0748
-75.08%

7/18

Active Buy Signals

Specific Signals

Short Term
Net score: 30.41
Signal Type Signal Value Importance Data
High / Low N/A Very Low $0.0748 - $0.0748
Trend - 3 mos 0 % High Width: 0.00000000000015 %
Pred. range - 3 mos $0.0748 - $0.0748 Low 0 % - 0 %
Volume Direction Sell High Volume: 1 · Direction: 0
Pivot Short Buy Very Low May 31, 2024 - 2 days
RSI Short Pivot Signal Buy Very Low Mar 15, 2024 - 55 days
Short MA 3 mos Sell Low Nov 30, -0001 - N/A days
Long MA 3 mos Sell Medium Nov 30, -0001 - N/A days
Short/Long MA 3 mos Sell Medium Nov 30, -0001 - N/A days

Unlock Short Term Signals

Get access to powerful short-term trading signals and real-time market insights

Subscribe Now
Long Term
Net score: 51.18
Signal Type Signal Value Importance Data
Trend - 12 mos -65.18 % Very High Width: 266.32 %
Pred. range - 12 mos N/A - $0.0795 High -100.00 % - 6.33 %
Short MA 12 mos Buy Very High Feb 26, 2024 - 69 days
Long MA 12 mos Buy Very High Sep 21, 2023 - 176 days
Short/Long MA 12 mos Sell Very High Nov 30, -0001 - N/A days
Pivot Long Buy Low Mar 04, 2024 - 64 days
RSI Long Pivot Signal Buy Low Mar 26, 2024 - 48 days
Bollinger Sell Medium Nov 30, -0001 - N/A days
MACD Neutral High No Dates Stored For This Signal
Click to get the best stock tips daily for free!
ABOUT BELLICUM PHARMACEUTICALS
Bellicum Pharmaceuticals
Bellicum Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel cellular immunotherapies for the treatment of hematological cancers and solid tumors in the United States and internationally. The company's clinical product candidates include BPX-601, an autologous GoCAR-T product candidate, which is in Phase 1/2 clinical trials for the treatment of solid tumors expressing the prostate stem ce...
GOLDEN STAR
Ticker Change Signal Date
EAT
$140.46
4.95% Jun 05
TPR
$140.47
0.320% Jun 04
N
NVRI
$19.53
4.92% May 20
GLBE
$31.61
3.54% May 05
FIZZ
$34.11
8.80% May 01

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE